Heart of Type 2

In the management of T2D, you target HbA1c, cholesterol and blood pressure. But are your patients still at risk?

Compared with patients without diabetes, patients with diabetes have a 2- to 6-times higher risk of mortality from CV events.1


People with diabetes are at increased risk for atherosclerotic CVD, including acute coronary syndrome, myocardial infarction, angina, stroke and peripheral artery disease.2



Even treatment with high-dose statins leaves residual CV risk in patients with diabetes (per the TNT study).3

  • Patients with diabetes and CHD treated with a high-dose statin had a 25% reduction in major CV events3
  • Still, 14% to 18% of patients experienced an event, even with therapy3

There is a need to address the residual risk for better patient outcomes.